Celanese Announces Agreement with Glaukos Corporation for Sustained Release Glaucoma Treatment
Celanese to Supply VitalDose Drug Delivery Platform for Glaukos’ Investigational iDose TR Intraocular Implant
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
06 Apr 23
Celanese to Supply VitalDose Drug Delivery Platform for Glaukos’ Investigational iDose TR Intraocular Implant
05 Apr 23
This milestone marks transition of Perfuse Therapeutics to a clinical-stage company
03 Apr 23
The Prima System is designed as a photovoltaic substitute for photoreceptors that offers simultaneous use of the central…
16 Mar 23
MINIject is said to be a minimally-invasive glaucoma surgery device that is currently the only commercially available MIGS…
13 Mar 23
The state-of-the-art technology is the only intraocular lens implant that enables eye care providers to non-surgically customize a…
10 Mar 23
The Ergo-Series maximizes ergonomics and surgical ease-of-use while continuing to enable surgeons to perform minimally invasive, implant-free glaucoma…
06 Mar 23
MINI WELL® EDOF IOL is an innovative IOL implant for the Greater China market, offering a great alternative…
03 Mar 23
The results demonstrated ViaLase FLigHT's potential as a safe and effective treatment option for primary open angle glaucoma
02 Mar 23
UV-absorbing contact lenses are not substitutes for protective UV-absorbing eyewear, such as UV-absorbing goggles or sunglasses, because they…
16 Feb 23
The findings from the study can offer useful insights to support the treatment paradigm for retinal disorders with…